Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I am all for a reverse split in the near future.
Reverse Split Advantages
Reverse splits can signal good news for investors or bad news. A reverse split can signal that a company is financially strong enough to be listed on an exchange. The stock price will increase enough to meet the exchange’s minimum price requirement. If you own stock in a small company that has seen increased sales and profits, the stock price should continue to rise after the reverse split.
Stocks newly listed on an exchange can attract new buyers, especially institutional investors who avoid over-the-counter and pink sheets stocks. Although you will end up owning fewer shares, they will be worth more as the price continues to rise.
Reverse Split Disadvantages
If your stock is listed on an exchange, a reverse split could herald a potential delisting as a consequence of its fallen price. If the stock remains below the exchange’s minimum price, the company’s stock is delisted and relegated to the over-the-counter market or the pink sheets.
The reverse split may boost the stock’s price for a while, but if sales have stalled or the company posts consecutive losses, the stock price will continue falling. Left unchecked, the stock will eventually be delisted off the exchange.
If the numbers are good in June and doing a reverse split gets us on the big boy board I am all for it!!! Bring it on!!
If the stock price doesn’t want to go up Elite might as well start buying it back at these cheapies with their NEW 1.3 BILLION DOLLAR DRUG REVENUES!!!! BOOM!!! Easy Money from here boys!! Confidence!!
Yep. Lol
Probably waiting for the Adderall XR launch. I would. Why spend all this money filling drugs if you can’t get any out the door.
All I know is Adderall XR launches in 2-4 weeks and I am not going to miss it for the world. See you at .24!
Moose
10:47 AM (57 minutes ago)
When will Adderall XR launch?
Rita Augustine <raugustine@lannett.com>
11:22 AM (22 minutes ago)
to CustomerService, me
Good day,
The launch is expected end of March /April 2020.
Please see www.Lannett.com products tab for product information.
Regards,
Client Relations Associate | Lannett Company Inc. | p: 215-333-9000 ext. 4 | f: 267-350-0069
CustomerService@lannett.com
I emailed Product info at Lannett.
They replied back and said
Adderall XR launches at the end of March/April 2020. GL
I like the Mar. 30 options calls on this stock. Taking a nice bounce off the 22. Should be back up to $30 soon.
It would be nice if this could slowly creep north to .01 before it decides to gain a ton of volume and let loose.
Yeah I always buy high and sell low too.
Good luck waiting
Really good consolidation going on! Just be heading north soon! IMO GL
Who cares. It is going to happen oh patience one.
Boom!!
Boom!!
Will do. I believe which will sound crazy but I can see this getting pumped up to .50 and then dumped back down to a .10 before the end of the year.
I bought 2 million yesterday. Lets do this!
The infection is viral and not bacterial so there are no drugs to stop it but maybe the could give the patients something to slow the progression.
You and me both!
Easy money here in the future! Fundamentals are at an all time high with higher returns guaranteed in the near future. From a technical standpoint looks like the long term charts have turned bullish also. A nice bull pennant has formed on the monthly chart!! The patient will prevail!!
None. Spot on post
Good luck on that. Not happening
Cash Flow Positive!!!
Elite's last ten 10Q's:
2017 Q3 Loss from operations (1,722,423)
2018 Q1 Loss from operations (2,238,271)
2018 Q2 Loss from operations (2,129,871)
2018 Q3 Loss from operations (2,058,961)
2019 Q1 Loss from operations (1,858,394)
2019 Q2 Loss from operations (2,652,972)
2019 Q3 Loss from operations (2,637,130)
2020 Q1 Loss from operations (1,147,705)
2020 Q2 Loss from operations (454,532)
2020 Q3 Income from operations + 691,195
Quote:
1ST PROFITABLE QUARTER IN ELITES HISTORY! This is a milestone as it was achieved on operations.
Cash Flow Positive ELTP!!
More monster revenues coming!!!!!
Elite Pharmaceuticals last ten 10Q's:
2017 Q3 Loss from operations (1,722,423)
2018 Q1 Loss from operations (2,238,271)
2018 Q2 Loss from operations (2,129,871)
2018 Q3 Loss from operations (2,058,961)
2019 Q1 Loss from operations (1,858,394)
2019 Q2 Loss from operations (2,652,972)
2019 Q3 Loss from operations (2,637,130)
2020 Q1 Loss from operations (1,147,705)
2020 Q2 Loss from operations (454,532)
2020 Q3 Income from operations + 691,195
Quote:
1ST PROFITABLE QUARTER IN ELITES HISTORY! This is a milestone as it was achieved on operations.
Cash Flow Positive ELTP!!
More monster revenues coming!!!!!
Elite Pharmaceuticals last ten 10Q's:
2017 Q3 Loss from operations (1,722,423)
2018 Q1 Loss from operations (2,238,271)
2018 Q2 Loss from operations (2,129,871)
2018 Q3 Loss from operations (2,058,961)
2019 Q1 Loss from operations (1,858,394)
2019 Q2 Loss from operations (2,652,972)
2019 Q3 Loss from operations (2,637,130)
2020 Q1 Loss from operations (1,147,705)
2020 Q2 Loss from operations (454,532)
2020 Q3 Income from operations + 691,195
Quote:
1ST PROFITABLE QUARTER IN ELITES HISTORY! This is a milestone as it was achieved on operations.
Cash Flow Positive ELTP!!
More monster revenues coming!!!!!
Elite Pharmaceuticals last ten 10Q's:
2017 Q3 Loss from operations (1,722,423)
2018 Q1 Loss from operations (2,238,271)
2018 Q2 Loss from operations (2,129,871)
2018 Q3 Loss from operations (2,058,961)
2019 Q1 Loss from operations (1,858,394)
2019 Q2 Loss from operations (2,652,972)
2019 Q3 Loss from operations (2,637,130)
2020 Q1 Loss from operations (1,147,705)
2020 Q2 Loss from operations (454,532)
2020 Q3 Income from operations + 691,195
Quote:
1ST PROFITABLE QUARTER IN ELITES HISTORY! This is a milestone as it was achieved on operations.
Cash Flow Positive ELTP!!
More monster revenues coming!!!!!
Elite Pharmaceuticals last ten 10Q's:
2017 Q3 Loss from operations (1,722,423)
2018 Q1 Loss from operations (2,238,271)
2018 Q2 Loss from operations (2,129,871)
2018 Q3 Loss from operations (2,058,961)
2019 Q1 Loss from operations (1,858,394)
2019 Q2 Loss from operations (2,652,972)
2019 Q3 Loss from operations (2,637,130)
2020 Q1 Loss from operations (1,147,705)
2020 Q2 Loss from operations (454,532)
2020 Q3 Income from operations + 691,195
Quote:
1ST PROFITABLE QUARTER IN ELITES HISTORY! This is a milestone as it was achieved on operations.
Cash Flow Positive ELTP!!
More monster revenues coming!!!!!
Elite Pharmaceuticals last ten 10Q's:
2017 Q3 Loss from operations (1,722,423)
2018 Q1 Loss from operations (2,238,271)
2018 Q2 Loss from operations (2,129,871)
2018 Q3 Loss from operations (2,058,961)
2019 Q1 Loss from operations (1,858,394)
2019 Q2 Loss from operations (2,652,972)
2019 Q3 Loss from operations (2,637,130)
2020 Q1 Loss from operations (1,147,705)
2020 Q2 Loss from operations (454,532)
2020 Q3 Income from operations + 691,195
Quote:
1ST PROFITABLE QUARTER IN ELITES HISTORY! This is a milestone as it was achieved on operations.
Cash Flow Positive ELTP!!
More monster revenues coming!!!!!
Elite Pharmaceuticals last ten 10Q's:
2017 Q3 Loss from operations (1,722,423)
2018 Q1 Loss from operations (2,238,271)
2018 Q2 Loss from operations (2,129,871)
2018 Q3 Loss from operations (2,058,961)
2019 Q1 Loss from operations (1,858,394)
2019 Q2 Loss from operations (2,652,972)
2019 Q3 Loss from operations (2,637,130)
2020 Q1 Loss from operations (1,147,705)
2020 Q2 Loss from operations (454,532)
2020 Q3 Income from operations + 691,195
Quote:
1ST PROFITABLE QUARTER IN ELITES HISTORY! This is a milestone as it was achieved on operations.
Cash Flow Positive ELTP!!
More monster revenues coming!!!!!
Elite Pharmaceuticals last ten 10Q's:
2017 Q3 Loss from operations (1,722,423)
2018 Q1 Loss from operations (2,238,271)
2018 Q2 Loss from operations (2,129,871)
2018 Q3 Loss from operations (2,058,961)
2019 Q1 Loss from operations (1,858,394)
2019 Q2 Loss from operations (2,652,972)
2019 Q3 Loss from operations (2,637,130)
2020 Q1 Loss from operations (1,147,705)
2020 Q2 Loss from operations (454,532)
2020 Q3 Income from operations + 691,195
Quote:
1ST PROFITABLE QUARTER IN ELITES HISTORY! This is a milestone as it was achieved on operations.
Cash Flow Positive ELTP!!
More monster revenues coming!!!!!
Elite Pharmaceuticals last ten 10Q's:
2017 Q3 Loss from operations (1,722,423)
2018 Q1 Loss from operations (2,238,271)
2018 Q2 Loss from operations (2,129,871)
2018 Q3 Loss from operations (2,058,961)
2019 Q1 Loss from operations (1,858,394)
2019 Q2 Loss from operations (2,652,972)
2019 Q3 Loss from operations (2,637,130)
2020 Q1 Loss from operations (1,147,705)
2020 Q2 Loss from operations (454,532)
2020 Q3 Income from operations + 691,195
Quote:
1ST PROFITABLE QUARTER IN ELITES HISTORY! This is a milestone as it was achieved on operations.
Cash Flow Positive ELTP!!
More monster revenues coming!!!!!
Elite Pharmaceuticals last ten 10Q's:
2017 Q3 Loss from operations (1,722,423)
2018 Q1 Loss from operations (2,238,271)
2018 Q2 Loss from operations (2,129,871)
2018 Q3 Loss from operations (2,058,961)
2019 Q1 Loss from operations (1,858,394)
2019 Q2 Loss from operations (2,652,972)
2019 Q3 Loss from operations (2,637,130)
2020 Q1 Loss from operations (1,147,705)
2020 Q2 Loss from operations (454,532)
2020 Q3 Income from operations + 691,195
Quote:
1ST PROFITABLE QUARTER IN ELITES HISTORY! This is a milestone as it was achieved on operations.
Cash Flow Positive!!
Wow look at that sell off!!! Zzzzzzz!!!
You too. Adderall ER launch shortly!!Thanks
Cash Flow Positive!!! How many companies are CFP!! Move North starts soon
Look again it is positive. No parentheses around it!
Just read it!! Boo yah!!
8.0 million